Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC concerns with "overbroad" patents should be communicated to policy makers -- staff report.

Executive Summary

FTC CONCERNS WITH "OVERBROAD" PATENT PROTECTION should be communicated to Congress, the Patent & Trademark Office, the courts and the Registrar of Copyrights, a Federal Trade Commission staff report on "Competition Policy in the New High-Tech, Global Marketplace" states. "FTC should continue to articulate to intellectual property policy makers the potential competitive consequences of overbroad patent rights and their aggressive enforcement," the report states. "Such a preventive approach is likely to reduce the number of instances in which antitrust enforcers are confronted with the complex task of parsing procompetitive and anticompetitive effects of business conduct involving intellectual property."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028346

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel